GlobalRPh Renal Dosing Masterv7.4
Renal Dosing Master: fast drug lookup
GlobalRPh source record

Famciclovir

Read renal action and limits

Famvir / Famciclovir

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Cautions / source differences (1)
Review first - source-specific qualification

Famvir - product and source limitations

The RX source names Famvir. The separately linked prescribing information is for a generic famciclovir oral tablet of matching form and strength.

Before applying: Consult the exact cited section and other applicable sources before use.

Evidence for this qualification

Selected renal passages reviewed; independent clinician adjudication pending.

Use the renal measure and units named by this source. Confirm product, indication, age, stable versus changing kidney function, and exact dialysis modality. The selected summary is not a complete prescribing monograph. Renal method and dosing checklist

Choose a source to read (3)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

Historical source

Original GlobalRPh source

Product / population
Preserved GlobalRPh source, not a freshly verified product label
Renal measure
Use the method specified in the original source
Source revision
Historical source; revision not established here
Retrieved
2026-09-05 (not the revision date)

Historical source: not automatically current. Review current official labeling and separately attributed additions before use.

Usual Dosing (Adults)

Herpes zoster: 500 mg orally every 8 hours for 7 days. Recurrent genital herpes: 125 mg twice daily for 5 days. Primary genital herpes: 250 mg three times daily for 5 to 10 days. Chronic genital-herpes suppression: 250 mg twice daily.

Renal Dosing

CrCl >60 mL/min: no change. CrCl 40 to 59: zoster 500 mg every 12 hours, other regimens unchanged. CrCl 20 to 39: zoster 500 mg every 24 hours; recurrent genital herpes 125 mg every 24 hours; suppression 125 mg every 12 hours. CrCl <20: zoster 250 mg every 24 hours; recurrent genital herpes and suppression 125 mg every 24 hours.

Hemodialysis

Recurrent genital herpes or suppression: 125 mg after each dialysis. Zoster or genital herpes in an HIV patient: 250 mg after each dialysis.

Source revision: Historical source; revision not established here | Retrieved: 2026-09-05. Retrieval date is not the revision date.

Source: https://globalrph.com/renal/famciclovir/

Scope: Preserved historical source; no fresh clinical approval GlobalRPh v7.4.

Full source card / provenance

All sources, comparison tools and evidence navigation
Added / rechecked in v7.4

Read source findings

Read source-specific summaries and their qualifications. Retrieval date is not label revision date. Recent review does not imply clinical approval.

Official

Famvir - labeled renal guidance

Retrieved: 2026-11-07
Source revision: DailyMed SPL version 4, posted Jan 16, 2026

Renal measure: Creatinine clearance (CrCl), mL/min

Read this dated source finding
Rxlist

Famvir - selected RX renal passage

Retrieved: 2026-11-07
Source revision: Mirror revision not established in the reviewed passage.

Renal measure: Use the renal measure explicitly present in the RX passage.

Read this dated source finding
See all retained evidence sources
Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Read 1 source difference / applicability notes

GlobalRPh RX List

Famvir - selected RX renal passage

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Famciclovir (Famvir), oral tablets; generic label comparison

Renal method: Use the renal measure explicitly present in the RX passage.
Retrieved: 2026-11-07

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Product / population check

Confirm the exact formulation before using a renal source

These links compare product identities, not interchangeable doses. A selected summary is not a complete prescribing monograph.

Source-specific review points

Read the attributed comparison notes and source cards below. No conflict has been silently adjudicated.

Source-quality holds
Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. This in-page search is processed in your browser. Do not enter patient identifiers; advertising scripts also run on this page.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Read before choosing a regimen

Source differences and product cautions

Search differences across all drugs

These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.

Source scope / renal recommendation differences

Famvir - product and source limitations

The RX source names Famvir. The separately linked prescribing information is for a generic famciclovir oral tablet of matching form and strength.

How to use this: The RX source names Famvir. The separately linked prescribing information is for a generic famciclovir oral tablet of matching form and strength.

Selected renal passages reviewed; independent clinician adjudication pending.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

Independent clinical review is pending. These selected summaries are not an approved institutional dosing protocol. Confirm the exact product, the complete current source and local policy before use.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Choose two source checkboxes below.
Historical source content is not a current prescription. Original GlobalRPh recommendations are preserved, not automatically certified as current. Product-label and professional additions below are separately attributed. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.
Locally stored source content

Original GlobalRPh protocol

Clinical facts and comments transcribed into a structured reading format. Read the original source for its complete context: https://globalrph.com/renal/famciclovir/

Usual Dosing (Adults)

Herpes zoster: 500 mg orally every 8 hours for 7 days. Recurrent genital herpes: 125 mg twice daily for 5 days. Primary genital herpes: 250 mg three times daily for 5 to 10 days. Chronic genital-herpes suppression: 250 mg twice daily.

GRPH-famciclovir-01 · Source section: Usual Dosing (Adults)Renal section finder

Renal Dosing

CrCl >60 mL/min: no change. CrCl 40 to 59: zoster 500 mg every 12 hours, other regimens unchanged. CrCl 20 to 39: zoster 500 mg every 24 hours; recurrent genital herpes 125 mg every 24 hours; suppression 125 mg every 12 hours. CrCl <20: zoster 250 mg every 24 hours; recurrent genital herpes and suppression 125 mg every 24 hours.

GRPH-famciclovir-02 · Source section: Renal DosingRenal section finder

Hemodialysis

Recurrent genital herpes or suppression: 125 mg after each dialysis. Zoster or genital herpes in an HIV patient: 250 mg after each dialysis.

GRPH-famciclovir-03 · Source section: HemodialysisRenal section finder
Separate U.S. product-label layer

FDA / DailyMed dosing and renal information

Official

Famvir - labeled renal guidance

Open original reference

Open / share this exact local source

DailyMed / product prescribing information · Famciclovir (Famvir), oral tablets; generic label comparison

Renal method: Creatinine clearance (CrCl), mL/min
Source date: DailyMed SPL version 4, posted Jan 16, 2026
Retrieved: 2026-11-07

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected renal passages reviewed; independent clinician adjudication pending.

Renal guidance: 2.1 and 2.3, Table 1

Limits that apply to these rows

The usual course is seven days. Genital and orolabial herpes use different regimens. The primary source is a matched generic oral tablet label.

Oral famciclovir for herpes zoster in immunocompetent adults
CrCl (mL/min) or modalityOral regimen
>=60500 mg every 8 hours
40-59500 mg every 12 hours
20-39500 mg every 24 hours
<20, off HD250 mg every 24 hours
Hemodialysis250 mg after each session
Read the retained text before reformatting

For immunocompetent adults with herpes zoster, use 500 mg every 8 hours at CrCl at least 60, every 12 hours at 40-59, and every 24 hours at 20-39 mL/min. Below 20, give 250 mg every 24 hours. In HD give 250 mg following each dialysis session. The usual course is seven days. Genital and orolabial herpes use different regimens. The primary source is a matched generic oral tablet label.

RDM74-famvir-official-1 · Source locator: Renal guidance: 2.1 and 2.3, Table 1

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c2b21ad5-fa83-1fb6-e053-2a95a90a3d0f
Retrieved
2026-11-07
Renal-function method
Creatinine clearance (CrCl), mL/min
Source date/version
DailyMed SPL version 4, posted Jan 16, 2026
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
7bd9c9bb94915aa96a74035a1a6cce7635658479580f96b4f048ba108571b54c
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

Famvir - selected RX renal passage

Open original reference

Open / share this exact local source

GlobalRPh RX List / product-label mirror · Famciclovir (Famvir), oral tablets; generic label comparison

Renal method: Use the renal measure explicitly present in the RX passage.
Source date: Mirror revision not established in the reviewed passage.
Retrieved: 2026-11-07

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.

Selected renal passages reviewed; independent clinician adjudication pending.

RX List: selected renal passage

The Famvir zoster table reduces the dose or extends the interval according to CrCl and gives a separate post-HD regimen.

RDM74-famvir-rxlist-1 · Source locator: RX List: selected renal passage

Source-specific limits

This mirror and the underlying product label share a source family.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/famvir-drug/
Retrieved
2026-11-07
Renal-function method
Use the renal measure explicitly present in the RX passage.
Source date/version
Mirror revision not established in the reviewed passage.
Hash meaning
SHA-256 of the local selected-source summary
Local summary SHA-256
932912905de8dbf0015a65262e144f6af3d18c73c7249dfc46ceddce8d425b53

Provenance and preservation

Additional summaries stored on this page: 1 official-label, 1 RX List, 0 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/renal/famciclovir/
Source retrieval
2026-09-05. This is not the source publication or label revision date.
Original source type
globalrph individual
Local text SHA-256
8bb0cedef4fa3444c49954b9cbdcdffa8493c780956e2bc78e60fc94dcd4b3c1
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

The original individual GlobalRPh pages commonly cite NIH/NLM DailyMed and instruct readers to review the applicable package insert for updates. That historical reference is preserved as context; it is not counted as an independently retrieved current label.

Read the full coverage report
Top